| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.2M | -33.2% |
| SG&A Expense | $1.8M | +119.0% |
| Operating Income | -$3.0M | -13.6% |
| Net Income | -$3.7M | -16.6% |
| EPS (Basic) | -$3.59 | — |
| EPS (Diluted) | -$3.59 | — |
| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $118K | -91.5% |
| Current Assets | $198K | -87.5% |
| Total Assets | $811K | -73.7% |
| Current Liabilities | $2.4M | +91.9% |
| Stockholders' Equity | -$1.6M | -190.4% |
| Line Item | 2022-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.7M | +32.6% |
| Investing Cash Flow | $25K | -96.1% |
| Financing Cash Flow | $390K | -84.1% |